Skip to content
10-K

Annual Report

CHINA-BIOTICS, INC

0001144204-13-039226

← back to feed
Filed
Jul 12, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Jul 10, 2013 22.15M sh
Shares Diluted FY 2012 · Mar 31, 2013 22.15M sh
Shares Diluted FY 2012 · Mar 31, 2012 22.27M sh
Operating Cash Flow FY 2012 · Mar 31, 2013 $23.97M
Operating Cash Flow FY 2012 · Mar 31, 2012 $1.29M
Long Term Debt FY 2012 · Mar 31, 2013 $15.96M
Long Term Debt FY 2012 · Mar 31, 2012 $7.91M
Short Term Debt FY 2012 · Mar 31, 2013 $15.96M
Short Term Debt FY 2012 · Mar 31, 2012 $3.17M
Cash And Equivalents FY 2012 · Mar 31, 2013 $75.87M
Cash And Equivalents FY 2012 · Mar 31, 2012 $70.09M
Cash And Equivalents FY 2012 · Mar 31, 2011 $143.99M
Stockholders Equity FY 2012 · Mar 31, 2013 $221.03M
Stockholders Equity FY 2012 · Mar 31, 2012 $202.43M
Stockholders Equity FY 2012 · Mar 31, 2011 $196.34M
Current Liabilities FY 2012 · Mar 31, 2013 $56.98M
Current Liabilities restated FY 2012 · Mar 31, 2012 $49.51M
Total Liabilities FY 2012 · Mar 31, 2013 $56.98M
Total Liabilities restated FY 2012 · Mar 31, 2012 $54.26M
Current Assets FY 2012 · Mar 31, 2013 $134.86M
Current Assets restated FY 2012 · Mar 31, 2012 $106.72M
Total Assets FY 2012 · Mar 31, 2013 $278.01M
Total Assets restated FY 2012 · Mar 31, 2012 $256.69M
Eps Diluted FY 2012 · Mar 31, 2013 $0.69
Eps Diluted FY 2012 · Mar 31, 2012 $0.12
Eps Basic FY 2012 · Mar 31, 2013 $0.69
Eps Basic FY 2012 · Mar 31, 2012 $0.13
Sga Expense FY 2012 · Mar 31, 2013 $12M
Sga Expense restated FY 2012 · Mar 31, 2012 $11.24M
Rd Expense FY 2012 · Mar 31, 2013 $4.85M
Rd Expense FY 2012 · Mar 31, 2012 $5.08M
Net Income FY 2012 · Mar 31, 2013 $15.38M
Net Income FY 2012 · Mar 31, 2012 $2.78M
Operating Income FY 2012 · Mar 31, 2013 $16.31M
Operating Income FY 2012 · Mar 31, 2012 $3.6M
Gross Profit FY 2012 · Mar 31, 2013 $46.71M
Gross Profit FY 2012 · Mar 31, 2012 $25.55M
Cost Of Revenue FY 2012 · Mar 31, 2013 $31.52M
Cost Of Revenue FY 2012 · Mar 31, 2012 $26.16M